Differential involvement of μ-opioid receptor subtypes in endomorphin-1-and-2-induced antinociception

被引:113
作者
Sakurada, S
Zadina, JE
Kastin, AJ
Katsuyama, S
Fujimura, T
Murayama, K
Yuki, M
Ueda, H
Sakurada, T
机构
[1] Tohoku Pharmaceut Univ, Dept Anat & Physiol, Sendai, Miyagi 9818558, Japan
[2] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
[3] Vet Affairs Med Ctr, New Orleans, LA USA
[4] Juntendo Univ, Sch Med, Cent Lab Med Sci, Div Biochem Anal, Tokyo 1138421, Japan
[5] Nagasaki Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol & Neurosci, Nagasaki 8528131, Japan
[6] Daiichi Coll Pharmaceut Sci, Dept Biochem, Minami Ku, Fukuoka 8158511, Japan
关键词
endomorphin-1; endomorphin-2; tail pressure test; naloxonazine; beta-funaltrexamine;
D O I
10.1016/S0014-2999(99)00181-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the role of mu-opioid receptor subtypes in both endomorphin-1 and endomorphin-2 induced antinociception in mice using supraspinally mediated behavior. With tail pressure as a mechanical noxious stimulus, both intracerebroventricularly (i.c.v.) and intrathecally (i.t.) injected-endomorphins produced potent and significant antinociceptive activity. Antinociception induced by i.t. and i.c.v. injection of endomorphin-1 was not reversed by pretreatment with a selective mu(1)-opioid receptor antagonist, naloxonazine (35 mg/kg, s.c.). By contrast, antinociception induced by i.t. and i.c.v. endomorphin-2 was significantly decreased by mu(1)-opioid receptor antagonist. Antinociception of both i.t. and i.c.v. endomorphin-1 and -2 was completely reversed by pretreatment with beta-funaltrexamine (40 mg/kg, s.c.). The results indicate that endomorphins may produce antinociception through the distinct mu(1) and mu(2) subtypes of mu-opioid receptor. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 22 条
[1]   Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha(2)-adrenoceptors [J].
Gergen, KA ;
Zadina, JE ;
Kastin, AJ ;
Paul, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (03) :235-239
[2]  
Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007
[3]   VISUALIZATION OF MU-1 OPIATE RECEPTORS IN RAT-BRAIN BY USING A COMPUTERIZED AUTORADIOGRAPHIC SUBTRACTION TECHNIQUE [J].
GOODMAN, RR ;
PASTERNAK, GW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) :6667-6671
[4]   PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE [J].
HALEY, TJ ;
MCCORMICK, WG .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (01) :12-15
[5]  
HEYMAN JS, 1988, J PHARMACOL EXP THER, V245, P238
[6]   INTRATHECAL MORPHINE IN MICE - A NEW TECHNIQUE [J].
HYLDEN, JLK ;
WILCOX, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 67 (2-3) :313-316
[7]  
IRWIN S, 1951, J PHARMACOL EXP THER, V101, P132
[8]   NALOXONAZINE ACTIONS INVIVO [J].
LING, GSF ;
SIMANTOV, R ;
CLARK, JA ;
PASTERNAK, GW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (1-2) :33-38
[9]  
LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[10]   Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene [J].
Matthes, HWD ;
Maldonado, R ;
Simonin, F ;
Valverde, O ;
Slowe, S ;
Kitchen, I ;
Befort, K ;
Dierich, A ;
LeMeur, M ;
Dolle, P ;
Tzavara, E ;
Hanoune, J ;
Roques, BP ;
Kieffer, BL .
NATURE, 1996, 383 (6603) :819-823